Free Trial
NYSE:BME

BlackRock Health Sciences Trust (BME) Stock Price, News & Analysis

BlackRock Health Sciences Trust logo
$43.38 +0.05 (+0.10%)
Closing price 10/2/2026 03:57 PM Eastern
Extended Trading
$43.68 +0.30 (+0.68%)
As of 10/2/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About BlackRock Health Sciences Trust Stock (NYSE:BME)

Advanced

Key Stats

Today's Range
$43.23
▼
$43.98
50-Day Range
$43.12
▼
$46.26
52-Week Range
$37.37
▼
$46.42
Volume
42,515 shs
Average Volume
44,310 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
7.24%
Price Target
N/A
Consensus Rating
N/A

Company Overview

BlackRock Health Sciences Trust (NYSE:BME) is a closed-end investment company focused on the global health sciences sector. The fund seeks to provide investors with total return through a combination of current income and capital appreciation by investing primarily in the equity securities of companies involved in health care and related industries.

Its portfolio may include companies engaged in pharmaceuticals, biotechnology, medical devices, health care services, diagnostics, and other areas supporting the development and delivery of health-related products and services. The trust can invest in businesses across the United States and international markets, giving shareholders exposure to a broad range of health sciences companies and geographies.

BlackRock Health Sciences Trust is managed by BlackRock Advisors, an affiliate of BlackRock, Inc. The fund has operated as a publicly traded closed-end fund since its inception in 2005. Like other closed-end funds, its shares trade on the New York Stock Exchange, while the portfolio is managed according to the trust’s stated investment objective and policies.

AI Generated. May Contain Errors.

Receive BME Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BlackRock Health Sciences Trust and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BME Stock News Headlines

BlackRock Health Sciences Trust
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.tc pixel
BlackRock Health Sciences Trust : BME
BME: Attractive Discount With Steady Monthly Distribution
See More Headlines

BME Stock Analysis - Frequently Asked Questions

BlackRock Health Sciences Trust's stock was trading at $41.17 at the start of the year. Since then, BME shares have increased by 5.4% and is now trading at $43.3850.

Shares of BME stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that BlackRock Health Sciences Trust investors own include Enterprise Products Partners (EPD), Verizon Communications (VZ), Mplx (MPLX), BlackRock Science and Technology Trust (BST), Johnson & Johnson (JNJ), Pfizer (PFE) and Main Street Capital (MAIN).

Company Calendar

Today
10/04/2026
Record date for 10/30 Dividend
10/15/2026
Ex-Dividend for 10/30 Dividend
10/15/2026
Dividend Payable
10/30/2026
Record date for 11/30 Dividend
11/13/2026
Ex-Dividend for 11/30 Dividend
11/13/2026
Dividend Payable
11/30/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Finance
Industry
Capital Markets
Sub-Industry
Asset Management & Custody Banks
Current Symbol
NYSE:BME
CIK
1314966
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$104.37 million
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (NYSE:BME) was last updated on 10/5/2026 by MarketBeat.com Staff.
From Our Partners